Protalix BioTherapeutics Statistics
Total Valuation
PLX has a market cap or net worth of $129.60 million. The enterprise value is $107.87 million.
Important Dates
The last earnings date was Thursday, November 14, 2024, before market open.
| Earnings Date | Nov 14, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
PLX has 73.63 million shares outstanding. The number of shares has decreased by -0.59% in one year.
| Current Share Class | 73.63M |
| Shares Outstanding | 73.63M |
| Shares Change (YoY) | -0.59% |
| Shares Change (QoQ) | +10.79% |
| Owned by Insiders (%) | 11.35% |
| Owned by Institutions (%) | 6.36% |
| Float | 54.75M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 3.69 |
| PS Ratio | 2.82 |
| Forward PS | 7.05 |
| PB Ratio | 4.00 |
| P/TBV Ratio | 4.00 |
| P/FCF Ratio | 18.07 |
| P/OCF Ratio | 15.66 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2.36 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 15.04 |
Financial Position
The company has a current ratio of 1.98, with a Debt / Equity ratio of 0.18.
| Current Ratio | 1.98 |
| Quick Ratio | 1.22 |
| Debt / Equity | 0.18 |
| Debt / EBITDA | n/a |
| Debt / FCF | 0.79 |
| Interest Coverage | -4.87 |
Financial Efficiency
Return on equity (ROE) is -27.18% and return on invested capital (ROIC) is -10.88%.
| Return on Equity (ROE) | -27.18% |
| Return on Assets (ROA) | -7.47% |
| Return on Capital (ROIC) | -10.88% |
| Revenue Per Employee | $219,553 |
| Profits Per Employee | -$46,183 |
| Employee Count | 208 |
| Asset Turnover | 0.61 |
| Inventory Turnover | 1.51 |
Taxes
In the past 12 months, PLX has paid $18,000 in taxes.
| Income Tax | 18,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +0.57% in the last 52 weeks. The beta is 0.74, so PLX's price volatility has been lower than the market average.
| Beta (5Y) | 0.74 |
| 52-Week Price Change | +0.57% |
| 50-Day Moving Average | 1.43 |
| 200-Day Moving Average | 1.21 |
| Relative Strength Index (RSI) | 63.36 |
| Average Volume (20 Days) | 382,380 |
Short Selling Information
The latest short interest is 3.10 million, so 4.21% of the outstanding shares have been sold short.
| Short Interest | 3.10M |
| Short Previous Month | 3.13M |
| Short % of Shares Out | 4.21% |
| Short % of Float | 5.66% |
| Short Ratio (days to cover) | 22.71 |
Income Statement
In the last 12 months, PLX had revenue of $45.67 million and -$9.61 million in losses. Loss per share was -$0.13.
| Revenue | 45.67M |
| Gross Profit | 16.38M |
| Operating Income | -8.91M |
| Pretax Income | 6.77M |
| Net Income | -9.61M |
| EBITDA | -7.62M |
| EBIT | -8.91M |
| Loss Per Share | -$0.13 |
Full Income StatementBalance Sheet
The company has $27.41 million in cash and $5.68 million in debt, giving a net cash position of $21.73 million or $0.30 per share.
| Cash & Cash Equivalents | 27.41M |
| Total Debt | 5.68M |
| Net Cash | 21.73M |
| Net Cash Per Share | $0.30 |
| Equity (Book Value) | 32.44M |
| Book Value Per Share | 0.44 |
| Working Capital | 23.63M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $8.28 million and capital expenditures -$1.11 million, giving a free cash flow of $7.17 million.
| Operating Cash Flow | 8.28M |
| Capital Expenditures | -1.11M |
| Free Cash Flow | 7.17M |
| FCF Per Share | $0.10 |
Full Cash Flow StatementMargins
Gross margin is 35.86%, with operating and profit margins of -19.50% and -21.03%.
| Gross Margin | 35.86% |
| Operating Margin | -19.50% |
| Pretax Margin | -21.00% |
| Profit Margin | -21.03% |
| EBITDA Margin | -16.69% |
| EBIT Margin | -19.50% |
| FCF Margin | 15.70% |